133 related articles for article (PubMed ID: 15730472)
1. Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection.
Komenaka IK; DeRaffele G; Hurst-Wicker KS; Kaufman HL
Breast J; 2005; 11(2):158-9. PubMed ID: 15730472
[No Abstract] [Full Text] [Related]
2. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
Kurul S; Taş F; Büyükbabani N; Mudun A; Baykal C; Camlica H
Jpn J Clin Oncol; 2005 Apr; 35(4):202-6. PubMed ID: 15845569
[TBL] [Abstract][Full Text] [Related]
3. Management of melanoma metastasis to the breast: case series and review of the literature.
Loffeld A; Marsden JR
Br J Dermatol; 2005 Jun; 152(6):1206-10. PubMed ID: 15948983
[TBL] [Abstract][Full Text] [Related]
4. [Breast metastases of skin melanoma].
Agnifili A; Giuliani M; Gianfelice F; D'Amore L; Negro P; Gossetti F; Carboni M
G Chir; 1990 Jun; 11(6):359-61. PubMed ID: 1701322
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of metastatic melanoma with interleukin-2.
Paciucci PA
Mt Sinai J Med; 1992 May; 59(3):238-43. PubMed ID: 1603114
[No Abstract] [Full Text] [Related]
6. Syndrome of inappropriate antidiuretic hormone secretion caused by high-dose bolus interleukin-2 therapy for metastatic melanoma.
Green MR; Woolery JE; Elquza E
Am J Ther; 2011 Sep; 18(5):e159-61. PubMed ID: 20592664
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous melanoma: available therapy for metastatic disease.
Tarhini AA; Agarwala SS
Dermatol Ther; 2006; 19(1):19-25. PubMed ID: 16405566
[TBL] [Abstract][Full Text] [Related]
9. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Powell S; Dudek AZ
Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery.
Martinez-Lopez A; Almazan-Fernandez FM; Perez-Lopez I; Aguayo-Carreras P; Salvador-Rodriguez L; Cuenca-Barrales C; Arias-Santiago S
Dermatol Ther; 2018 Jul; 31(4):e12612. PubMed ID: 29766618
[No Abstract] [Full Text] [Related]
11. Breast metastases from cutaneous malignant melanoma.
Bassi F; Gatti G; Mauri E; Ballardini B; De Pas T; Luini A
Breast; 2004 Dec; 13(6):533-5. PubMed ID: 15563866
[No Abstract] [Full Text] [Related]
12. Multiple Pigmented Lesions of the Breast Following Ipsilateral Breast Carcinoma.
Limmer A; Swali R; Robare S
Am J Med; 2020 Aug; 133(8):926-927. PubMed ID: 31987804
[No Abstract] [Full Text] [Related]
13. Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma.
Bernhardt MB; Hicks MJ; Pappo AS
Pediatr Blood Cancer; 2009 Dec; 53(7):1346-8. PubMed ID: 19731326
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous head and neck melanoma: the old and the new.
Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma.
Safwat A; Schmidt H; Bastholt L; Fode K; Larsen S; Aggerholm N; von der Maase H
Radiother Oncol; 2005 Nov; 77(2):143-7. PubMed ID: 16216360
[TBL] [Abstract][Full Text] [Related]
16. More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.
McDermott DF; Atkins MB
J Clin Oncol; 2007 Sep; 25(25):3791-3. PubMed ID: 17761967
[No Abstract] [Full Text] [Related]
17. Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines.
Patel F; Wilken R; Burrall B; Martinez S; Wells V; King B; Maverakis E
Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419744
[TBL] [Abstract][Full Text] [Related]
18. [Metastasis of a melanoma in the breast].
Liszka G; Molnár L; Szabó E
Zentralbl Chir; 1986; 111(15):935-7. PubMed ID: 3765937
[No Abstract] [Full Text] [Related]
19. Breast metastases as the first sign of recurrence of a cutaneous melanoma.
Sampedro Gimeno T; Moreno Antón F; López-Tarruella Cobo S; González Larriba JL; Furio Bacete V; Díaz-Rubio García E
Clin Transl Oncol; 2006 Jan; 8(1):57-9. PubMed ID: 16632442
[TBL] [Abstract][Full Text] [Related]
20. [High-dose Roncoleukin in patients with disseminated cutaneous melanoma: a phase 1 study].
Moiseenko VM; Novik AV; Orlova RV; Protsenko SA; Mikhaĭlichenko TD; Semenova AI; Tiukavina NV
Vopr Onkol; 2005; 51(5):546-9. PubMed ID: 16756008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
